Haichu Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Haichu Yu has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Meng-Meng Wang
Department of Cardiology, The Affiliated Hospital of Qingdao University
8 shared publications- Ning Zhang
Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China
8 shared publications Rui Chen
Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China
7 shared publicationsTian-Qi Teng
Department of Cardiology, The Affiliated Hospital of Qingdao University
7 shared publicationsJiachao Xu
Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, Shandong, China
6 shared publications- Meng-Meng Wang
Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China
6 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1980534
Association of the triglyceride-glucose index with elevated somatic symptoms: a cross-sectional study in patients with hypertension
Background: Insulin resistance is a key component of cardiometabolic dysfunction and has been associated with adverse health outcomes. The triglyceride–glucose (TyG) index is a surrogate marker of insulin resistance. Elevated somatic symptoms are common but may be underrecognized among patients with hypertension. However, the association between TyG and elevated somatic symptoms remains unclear. Methods: Patients with hypertension were consecutively recruited from the Affiliated Cardiovascular Hospital of Qingdao University between 2022 and 2023. Elevated somatic symptoms were assessed using the Chinese version of the Somatic Self-rating Scale (SSS-CN), with an SSS-CN score ≥30 defining elevated somatic symptoms. Multivariable regression models were used to evaluate the associations of TyG with elevated somatic symptoms. The incremental value of TyG beyond traditional clinical variables was assessed using model discrimination, reclassification, calibration, and decision curve analysis. Additive interaction analyses were performed to evaluate the joint effects of TyG with anxiety and depression. Sensitivity analyses were conducted to assess the robustness of the findings. Results: Among 2,422 participants, 540 (22.3%) were classified as having elevated somatic symptoms. In fully adjusted models, TyG was positively associated with elevated somatic symptoms. Compared with Q1, the adjusted odds ratios for Q2–Q4 were 1.21 (95% CI: 0.89–1.64), 1.54 (95% CI: 1.15–2.08), and 1.87 (95% CI: 1.38–2.54), respectively. Adding TyG to traditional clinical variables improved model performance, with the area under the curve increasing from 0.704 (95% CI: 0.678–0.729) to 0.717 (95% CI: 0.692–0.742; DeLong test, P = 0.004). The addition of TyG also improved reclassification and discrimination (NRI = 0.3057, 95% CI: 0.2149–0.3955; IDI = 0.0143, 95% CI: 0.0080–0.0213; both P < 0.001). Statistically significant additive interactions were observed between elevated TyG and anxiety or depression in relation to elevated somatic symptoms. Sensitivity analyses yielded consistent results. Conclusions: TyG was associated with elevated somatic symptoms among patients with hypertension, with additive interactions observed between TyG and anxiety or depression. TyG may provide additional information for assessing elevated somatic symptoms beyond traditional clinical variables.
- 9 November 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1980534
Open AccessAssociation of the triglyceride-glucose index with elevated somatic symptoms: a cross-sectional study in patients with hypertension
Background: Insulin resistance is a key component of cardiometabolic dysfunction and has been associated with adverse health outcomes. The triglyceride–glucose (TyG) index is a surrogate marker of insulin resistance. Elevated somatic symptoms are common but may be underrecognized among patients with hypertension. However, the association between TyG and elevated somatic symptoms remains unclear. Methods: Patients with hypertension were consecutively recruited from the Affiliated Cardiovascular Hospital of Qingdao University between 2022 and 2023. Elevated somatic symptoms were assessed using the Chinese version of the Somatic Self-rating Scale (SSS-CN), with an SSS-CN score ≥30 defining elevated somatic symptoms. Multivariable regression models were used to evaluate the associations of TyG with elevated somatic symptoms. The incremental value of TyG beyond traditional clinical variables was assessed using model discrimination, reclassification, calibration, and decision curve analysis. Additive interaction analyses were performed to evaluate the joint effects of TyG with anxiety and depression. Sensitivity analyses were conducted to assess the robustness of the findings. Results: Among 2,422 participants, 540 (22.3%) were classified as having elevated somatic symptoms. In fully adjusted models, TyG was positively associated with elevated somatic symptoms. Compared with Q1, the adjusted odds ratios for Q2–Q4 were 1.21 (95% CI: 0.89–1.64), 1.54 (95% CI: 1.15–2.08), and 1.87 (95% CI: 1.38–2.54), respectively. Adding TyG to traditional clinical variables improved model performance, with the area under the curve increasing from 0.704 (95% CI: 0.678–0.729) to 0.717 (95% CI: 0.692–0.742; DeLong test, P = 0.004). The addition of TyG also improved reclassification and discrimination (NRI = 0.3057, 95% CI: 0.2149–0.3955; IDI = 0.0143, 95% CI: 0.0080–0.0213; both P < 0.001). Statistically significant additive interactions were observed between elevated TyG and anxiety or depression in relation to elevated somatic symptoms. Sensitivity analyses yielded consistent results. Conclusions: TyG was associated with elevated somatic symptoms among patients with hypertension, with additive interactions observed between TyG and anxiety or depression. TyG may provide additional information for assessing elevated somatic symptoms beyond traditional clinical variables.
- 1 October 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (10)
Research Advances in Spontaneous Coronary Artery Dissection
Spontaneous coronary artery dissection (SCAD) is a condition characterized by myocardial injury resulting from the rupture of the coronary artery intima or the formation of an intramural hematoma and is unrelated to atherosclerosis. Recent studies have reported that SCAD accounts for 1% to 4% of cases of acute coronary syndrome in patients, with 90% of these patients being women. The widespread use of intravascular ultrasound and optical coherence tomography has significantly improved the diagnostic sensitivity of SCAD. Currently, specific clinical practice guidelines for SCAD are unavailable, and clinical decision-making relies primarily on observational data and expert recommendations. Therefore, further research on this condition will help guide clinical management and improve patient outcomes. On the basis of previous research findings and case reports, this review summarizes the latest advances in understanding the pathogenesis, pathophysiology, and epidemiology of SCAD, with a focus on clinical diagnostic methods, treatment strategies, and long-term management, thereby providing a reference for future clinical and scientific research.
- 1 October 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 19 (10)
Research Advances in Spontaneous Coronary Artery Dissection
Spontaneous coronary artery dissection (SCAD) is a condition characterized by myocardial injury resulting from the rupture of the coronary artery intima or the formation of an intramural hematoma and is unrelated to atherosclerosis. Recent studies have reported that SCAD accounts for 1% to 4% of cases of acute coronary syndrome in patients, with 90% of these patients being women. The widespread use of intravascular ultrasound and optical coherence tomography has significantly improved the diagnostic sensitivity of SCAD. Currently, specific clinical practice guidelines for SCAD are unavailable, and clinical decision-making relies primarily on observational data and expert recommendations. Therefore, further research on this condition will help guide clinical management and improve patient outcomes. On the basis of previous research findings and case reports, this review summarizes the latest advances in understanding the pathogenesis, pathophysiology, and epidemiology of SCAD, with a focus on clinical diagnostic methods, treatment strategies, and long-term management, thereby providing a reference for future clinical and scientific research.
- Open Access
- 10 March 2026
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 25 (1)
Inflammation mediates the association between the triglyceride-glucose index and non-target lesions progression after PCI: a cohort study
The progression of non-target lesions (NTLs) following percutaneous coronary intervention (PCI) is an important clinical issue, yet the role of triglycerid
- 10 March 2026
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 25 (1)
Open AccessInflammation mediates the association between the triglyceride-glucose index and non-target lesions progression after PCI: a cohort study
The progression of non-target lesions (NTLs) following percutaneous coronary intervention (PCI) is an important clinical issue, yet the role of triglycerid
- 21 February 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 403, 121400
Neuroticism as a protective factor for cardiomyopathy: A mediation Mendelian randomization study
- 21 February 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 403, 121400
Neuroticism as a protective factor for cardiomyopathy: A mediation Mendelian randomization study
- Open Access
Genetic evidence supports primary biliary cholangitis as a risk factor for lacunar stroke
- Open Access
- 6 November 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (2) , 5474-5476
A commentary on “Association of social isolation and loneliness with the incidence and life expectancy of chronic kidney disease: a population-based cohort study”
- 6 November 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (2) , 5474-5476
Open AccessA commentary on “Association of social isolation and loneliness with the incidence and life expectancy of chronic kidney disease: a population-based cohort study”
- Open Access
- 13 October 2025
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 24 (1) , 315
Exploring the relationship between residual cholesterol, body mass index, and hypertension risk: a national cohort study
Recent studies suggest a link between residual cholesterol (RC) and hypertension, but the mechanisms remain unclear. Exploring modifiable factors like RC may contribute to chronic disease management. A total of 1,788 individuals aged 45 years or older were selected from the China Health and Retirement Longitudinal Study (CHARLS), which was conducted from 2011 to 2020. Participants with a baseline BMI ≥ 24 kg/m² or diagnosis of hypertension in 2013 or earlier were excluded. Here, baseline RC levels were treated as the exposure factor, BMI from the 2013 follow-up as the mediator, and incident hypertension from the 2015-2020 follow-up as the outcome variable. This study examined the effect of RC and BMI on hypertension by focusing on the role of BMI in the underlying mechanisms. Additionally, cross-sectional data from the 2011 CHARLS were included to validate the stability of the mediating relationships. After a two-year follow-up (2013), 186 participants (10.4%) developed overweight or obesity (BMI ≥ 24 kg/m²). Within a median follow-up of five years (2015-2020), 24% (430 individuals) experienced the onset of hypertension. RC levels rising by 1 mmol/L were tied to a 4% increase in the risk of overweight/obesity (OR = 1.04, 95% CI: 1.01-1.08). Similarly, an increase of 1 mmol/L in RC was linked to a 30% increased risk of developing hypertension (HR = 1.3, 95% CI: 1.1-1.55). BMI-2013 was significantly associated with incident hypertension (OR = 1.07, 95% CI: 1.03-1.11). These findings remained stable after adjusting for covariates. BMI-2013 was identified as a key mediator in the connection between RC and hypertension, with an indirect effect of β = 0.008 (95% CI: 0.003-0.01, p = 0.02) and a total effect of β = 0.064 (95% CI: 0.017-0.110, p < 0.001), accounting for 11.8% of the total effect (P = 0.02). Sensitivity analysis of the cross-sectional data suggested that the results were stable. RC may contribute to hypertension development, with BMI potentially acting as a mediator. These findings highlight the importance of metabolic risk control in reducing the burden of chronic diseases.
- 13 October 2025
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 24 (1) , 315
Open AccessExploring the relationship between residual cholesterol, body mass index, and hypertension risk: a national cohort study
Recent studies suggest a link between residual cholesterol (RC) and hypertension, but the mechanisms remain unclear. Exploring modifiable factors like RC may contribute to chronic disease management. A total of 1,788 individuals aged 45 years or older were selected from the China Health and Retirement Longitudinal Study (CHARLS), which was conducted from 2011 to 2020. Participants with a baseline BMI ≥ 24 kg/m² or diagnosis of hypertension in 2013 or earlier were excluded. Here, baseline RC levels were treated as the exposure factor, BMI from the 2013 follow-up as the mediator, and incident hypertension from the 2015-2020 follow-up as the outcome variable. This study examined the effect of RC and BMI on hypertension by focusing on the role of BMI in the underlying mechanisms. Additionally, cross-sectional data from the 2011 CHARLS were included to validate the stability of the mediating relationships. After a two-year follow-up (2013), 186 participants (10.4%) developed overweight or obesity (BMI ≥ 24 kg/m²). Within a median follow-up of five years (2015-2020), 24% (430 individuals) experienced the onset of hypertension. RC levels rising by 1 mmol/L were tied to a 4% increase in the risk of overweight/obesity (OR = 1.04, 95% CI: 1.01-1.08). Similarly, an increase of 1 mmol/L in RC was linked to a 30% increased risk of developing hypertension (HR = 1.3, 95% CI: 1.1-1.55). BMI-2013 was significantly associated with incident hypertension (OR = 1.07, 95% CI: 1.03-1.11). These findings remained stable after adjusting for covariates. BMI-2013 was identified as a key mediator in the connection between RC and hypertension, with an indirect effect of β = 0.008 (95% CI: 0.003-0.01, p = 0.02) and a total effect of β = 0.064 (95% CI: 0.017-0.110, p < 0.001), accounting for 11.8% of the total effect (P = 0.02). Sensitivity analysis of the cross-sectional data suggested that the results were stable. RC may contribute to hypertension development, with BMI potentially acting as a mediator. These findings highlight the importance of metabolic risk control in reducing the burden of chronic diseases.
- 15 August 2025
- Published by Elsevier in International Journal of Cardiology
- Vol. 441, 133786
sIL-6R impact on aortic aneurysm: Genetic evidence from FinnGen and GWAS
- 15 August 2025
- Published by Elsevier in International Journal of Cardiology
- Vol. 441, 133786
sIL-6R impact on aortic aneurysm: Genetic evidence from FinnGen and GWAS
- Open Access
- 5 August 2025
- Published by Springer Nature in BMC Medicine
- Vol. 23 (1) , 1-14
Efficiency of remote monitoring and guidance in blood pressure management: a randomized controlled trial
Regular monitoring of blood pressure (BP) is essential for managing hypertension. The long-term effectiveness of remote monitoring in BP control requires further validation. Although self-monitoring has some benefits, its overall effectiveness remains inconclusive. In this study, we aimed to compare whether remote monitoring and self-monitoring differ from usual care in terms of their effects on BP reduction in patients with hypertension. This multicentre randomised controlled trial enrolled participants diagnosed with primary hypertension in Qingdao, China, from December 2020 to December 2021. Patients were randomly assigned to one of the following three groups: remote monitoring, self-monitoring, or usual care. All groups underwent scheduled outpatient follow-up visits every 3 months throughout the 24-month study period. The primary outcome was the adjusted mean difference in systolic BP, which was used to evaluate the effectiveness of remote monitoring and self-monitoring compared to usual care. A total of 1006 participants were analysed: 332 in the usual care group, 337 in the self-monitoring group, and 337 in the remote group. After 24 months, BP was significantly reduced in all the groups, particularly in the remote group with suboptimal baseline BP, where systolic and diastolic BP decreased by 17.7 mm Hg and 10.2 mm Hg, respectively. Compared to the usual care group, the adjusted mean difference in systolic BP for the remote group was -2.7 (-4.45, -0.96), p = 0.002, while the self-monitoring group showed no significant difference. No significant differences in diastolic BP were observed between either group and the usual care group. Attainment rates of target BP increased rapidly in the first 3 months, and continued to rise only in the remote group, reaching 69.65%. The remote group had a higher proportion of calcium channel blockers, diuretics, and combination therapy than the usual care and self-monitoring groups. Remote monitoring and guidance enhanced the efficiency of BP management, whereas self-monitoring alone proved to be ineffective. ClincialTrials.gov Identifier: NCT04690478.
- 5 August 2025
- Published by Springer Nature in BMC Medicine
- Vol. 23 (1) , 1-14
Open AccessEfficiency of remote monitoring and guidance in blood pressure management: a randomized controlled trial
Regular monitoring of blood pressure (BP) is essential for managing hypertension. The long-term effectiveness of remote monitoring in BP control requires further validation. Although self-monitoring has some benefits, its overall effectiveness remains inconclusive. In this study, we aimed to compare whether remote monitoring and self-monitoring differ from usual care in terms of their effects on BP reduction in patients with hypertension. This multicentre randomised controlled trial enrolled participants diagnosed with primary hypertension in Qingdao, China, from December 2020 to December 2021. Patients were randomly assigned to one of the following three groups: remote monitoring, self-monitoring, or usual care. All groups underwent scheduled outpatient follow-up visits every 3 months throughout the 24-month study period. The primary outcome was the adjusted mean difference in systolic BP, which was used to evaluate the effectiveness of remote monitoring and self-monitoring compared to usual care. A total of 1006 participants were analysed: 332 in the usual care group, 337 in the self-monitoring group, and 337 in the remote group. After 24 months, BP was significantly reduced in all the groups, particularly in the remote group with suboptimal baseline BP, where systolic and diastolic BP decreased by 17.7 mm Hg and 10.2 mm Hg, respectively. Compared to the usual care group, the adjusted mean difference in systolic BP for the remote group was -2.7 (-4.45, -0.96), p = 0.002, while the self-monitoring group showed no significant difference. No significant differences in diastolic BP were observed between either group and the usual care group. Attainment rates of target BP increased rapidly in the first 3 months, and continued to rise only in the remote group, reaching 69.65%. The remote group had a higher proportion of calcium channel blockers, diuretics, and combination therapy than the usual care and self-monitoring groups. Remote monitoring and guidance enhanced the efficiency of BP management, whereas self-monitoring alone proved to be ineffective. ClincialTrials.gov Identifier: NCT04690478.
- Open Access
- 11 July 2025
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 24 (1) , 1-22
Derivatives of the triglyceride–glucose index and their association with incident hypertension in prehypertensive individuals: a 4-year cohort study augmented by mendelian randomization
The direct association between elevated levels of the triglyceride-glucose index (TyG index) and its derived metrics and the risk of new-onset hypertension in prehypertensive populations remains unclear. The study systematically evaluated the link between the TyG index and its related indicators with new-onset hypertension by integrating cohort study methods with Mendelian randomization (MR) analysis. A total of 2,815 prehypertensive participants from the 2011 CHARLS database were included, of whom 877 (31.15%) progressed to new-onset hypertension by 2015. TyG-Waist-to-Height Ratio (TyG-WHtR), TyG-Body Mass Index (TyG-BMI), TyG-Waist Circumference (TyG-WC), and the TyG index were calculated. Logistic regression, restricted cubic spline (RCS) curves, subgroup analyses, and interaction tests were performed to assess the associations. Bayesian weighted MR (BWMR) was further used to validate causal relationships. Multivariable regression analysis revealed that each unit increase in the TyG index was associated with a 45% higher risk of new-onset hypertension (odds ratio [OR]: 1.45, 95% confidence intervals [CI] 1.24–1.70, P < 0.001), while TyG-WHtR showed a 42% increased risk (OR: 1.42, 95% CI 1.26–1.60, P < 0.001). Categorizing the TyG and its derived metrics by quartiles demonstrated that higher quartiles (Q3 and Q4) were significantly linked to an elevated risk of new-onset hypertension across all models (P < 0.001). RCS models indicated significant positive linear relationships between the TyG index and TyG-WC with new-onset hypertension (P for overall < 0.001, P for nonlinearity = 0.844 and 0.165, respectively), whereas TyG-WHtR and TyG-BMI exhibited significant positive nonlinear relationships (P for overall < 0.001, P for nonlinearity = 0.001 and 0.046, respectively). Subgroup analyses highlighted stronger associations among individuals aged ≥ 70 years, those who were widowed, had cardiovascular disease, or reported a life satisfaction score of 2 (P < 0.05, P for interaction < 0.05). BWMR analysis confirmed a significant causal relationship between genetically elevated TyG index levels and an increased risk of new-onset hypertension (P < 0.05). Our study reveals a significant link between the TyG index and its related indicators with new-onset hypertension in prehypertensive populations. Causal analysis using BWMR confirmed that genetically elevated TyG index levels increase the risk of new-onset hypertension. These results highlight the importance of monitoring TyG-related indices for early detection and intervention in high-risk individuals, aiding in the prevention of hypertension progression.
- 11 July 2025
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 24 (1) , 1-22
Open AccessDerivatives of the triglyceride–glucose index and their association with incident hypertension in prehypertensive individuals: a 4-year cohort study augmented by mendelian randomization
The direct association between elevated levels of the triglyceride-glucose index (TyG index) and its derived metrics and the risk of new-onset hypertension in prehypertensive populations remains unclear. The study systematically evaluated the link between the TyG index and its related indicators with new-onset hypertension by integrating cohort study methods with Mendelian randomization (MR) analysis. A total of 2,815 prehypertensive participants from the 2011 CHARLS database were included, of whom 877 (31.15%) progressed to new-onset hypertension by 2015. TyG-Waist-to-Height Ratio (TyG-WHtR), TyG-Body Mass Index (TyG-BMI), TyG-Waist Circumference (TyG-WC), and the TyG index were calculated. Logistic regression, restricted cubic spline (RCS) curves, subgroup analyses, and interaction tests were performed to assess the associations. Bayesian weighted MR (BWMR) was further used to validate causal relationships. Multivariable regression analysis revealed that each unit increase in the TyG index was associated with a 45% higher risk of new-onset hypertension (odds ratio [OR]: 1.45, 95% confidence intervals [CI] 1.24–1.70, P < 0.001), while TyG-WHtR showed a 42% increased risk (OR: 1.42, 95% CI 1.26–1.60, P < 0.001). Categorizing the TyG and its derived metrics by quartiles demonstrated that higher quartiles (Q3 and Q4) were significantly linked to an elevated risk of new-onset hypertension across all models (P < 0.001). RCS models indicated significant positive linear relationships between the TyG index and TyG-WC with new-onset hypertension (P for overall < 0.001, P for nonlinearity = 0.844 and 0.165, respectively), whereas TyG-WHtR and TyG-BMI exhibited significant positive nonlinear relationships (P for overall < 0.001, P for nonlinearity = 0.001 and 0.046, respectively). Subgroup analyses highlighted stronger associations among individuals aged ≥ 70 years, those who were widowed, had cardiovascular disease, or reported a life satisfaction score of 2 (P < 0.05, P for interaction < 0.05). BWMR analysis confirmed a significant causal relationship between genetically elevated TyG index levels and an increased risk of new-onset hypertension (P < 0.05). Our study reveals a significant link between the TyG index and its related indicators with new-onset hypertension in prehypertensive populations. Causal analysis using BWMR confirmed that genetically elevated TyG index levels increase the risk of new-onset hypertension. These results highlight the importance of monitoring TyG-related indices for early detection and intervention in high-risk individuals, aiding in the prevention of hypertension progression.